Rotavirus Vaccination Likely to Be Cost Saving to Society in the United States.
Anthony T NewallRobert Neil LeongJosephine F ReyesAaron T CurnsJessica RuddJacqueline TateKristine MacartneyUmesh ParasharPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
After the program stabilized, we found the rotavirus immunization in the United States was likely to have been cost saving to society. The greater than expected healthcare and productivity savings reflect the success of the rotavirus immunization program in the United States.